# Phase 2 Independent Internal Audit

## Executive summary

An independent post-implementation review re-read the governing scope, inspected every Phase 2 module and contract, traced the connected data-to-publication lifecycle, and attempted adversarial bypasses. Defects found during the review—unauthenticated prepared frames, missing RF output, non-directional scores, daily rather than approved monthly portfolio formation, crash-retry evidence collision, path escape, read-time checksum races, incomplete prepared-input contracts, and insufficient range/null checks—were remediated and regression-tested before this report.

Final open findings: zero Critical, zero High, zero merge blockers. Phase 2 acceptance criteria pass. The remaining warnings are operational or governance limitations that do not permit fabricated or unauthenticated research.

## Audit scope and method

The audit covered configuration, data contracts, owner-input ingestion, Phase 1 authenticated access, temporal alignment, all factor definitions, preprocessing, scores, portfolio formation, diagnostics, validation, persistence, CLI, tests, documentation, dependencies, Git diff/status, secrets, paths, and generated artifacts. It did not rely on a prior Phase 2 report.

Review methods included source tracing, contract comparison, exact formula inspection, malformed input mutations, future-timestamp injection, parent and role forgery, unit contradiction, canonical-ID mismatch, path traversal, byte tampering, publication-envelope substitution, crash injection, restart, deterministic rerun, and full quality gates.

## Connected lifecycle audit

PASS. Owner-prepared factor inputs use registered strict data contracts and normal Phase 1 raw, validation, units, mapping, lineage, lifecycle, promotion, and research-read controls. Phase 2 accepts exactly one authenticated market and one authenticated fundamental artifact. No public API accepts a caller data frame. Parent artifacts are re-hashed and parsed from the same in-memory bytes.

## Temporal and bias audit

PASS. Market observation, universe eligibility, classification, and fundamental availability must be known by cutoff and propagate downstream. Fundamentals join backward by security and field. Missing values remain missing. Membership is explicit per date; current membership is never projected backward. Monthly portfolios form at month end and realize only later observations. Tests reject future eligibility, classifications, filings, market evidence, and same-date portfolio realization.

## Factor and preprocessing audit

PASS. The registry contains 48 required outputs, including market total/excess/RF/beta; the complete size/value/momentum/quality/investment/low-volatility/liquidity/risk catalog; and no later-phase model. Formulas use safe division, valid simple-return compounding, configured windows and annualization, XNYS breakpoints, and preferred directions. Raw, winsorized, normalized, and scored values persist separately. Every supported normalization method was exercised.

## Portfolio and diagnostics audit

PASS. Continuous characteristics use direction-aligned month-end terciles, formation-date market-cap weights, following-period compounded simple returns, authenticated benchmark returns, and active returns. Common market/RF series and discrete size indicators are excluded from arbitrary tied-rank portfolios. Diagnostics cover coverage, outliers, correlations, monthly turnover, group returns, descriptive t-statistics, monotonicity, and rolling active returns. No cost-adjusted or statistical-success claim is made without owner decisions.

## Publication, restart, and read-time audit

PASS. Staging is outside discoverable one-level publication paths; activation is an atomic directory replace. Injected pre-activation failure produced zero authenticated publications and retry produced exactly one. Artifact/configuration/validation/diagnostic/lineage/manifest/envelope changes were rejected. Schema, byte size, checksums, IDs, parent roles, configuration, Git commit, and validation identity are connected. Parent and factor readers hash the exact bytes parsed, closing time-of-check/time-of-use substitution.

## Security and repository audit

PASS. Output paths reject absolute and parent traversal. Current source/docs contain no private absolute path or high-confidence credential. No tracked dataset, Parquet file, database, cache, `.env`, coverage artifact, or generated research output exists. Dependencies are locked and compatible. No internal import cycle was found.

## Acceptance matrix

| Area | Result |
|---|---|
| Complete authorized factor catalog | PASS |
| Point-in-time data and publication lag | PASS |
| Survivorship and classification controls | PASS |
| Missingness and outliers | PASS |
| Configurable normalization/neutralization/direction | PASS |
| Monthly factor diagnostics and benchmark comparison | PASS |
| Metadata, lineage, immutable publication | PASS |
| Restart and collision safety | PASS |
| Authenticated read-time isolation | PASS |
| Tests/coverage/static gates | PASS |
| Documentation consistency | PASS |
| Phase boundary | PASS |

## Complete defect register

| ID | Severity | Evidence and consequence | Disposition | Merge blocking |
|---|---|---|---|---|
| P2-W01 | Low | No live point-in-time issuer-scale dataset was supplied; empirical coverage and economic behavior are unvalidated | Disclosed; live inputs must pass authenticated contracts; no empirical claim | No |
| P2-W02 | Low | Cost and formal significance thresholds remain unapproved | Gross descriptive returns/t-statistics only; no success label or net claim | No |
| P2-W03 | Low | Existing calendar dependency emits four future deprecation warnings | Compatibility tests pass; monitor upstream package | No |

All Critical and High defects discovered during investigation were fixed before final classification and have regression evidence. No finding was hidden or downgraded.

## Phase 3 readiness

Phase 3 may consume only authenticated Phase 2 publications through `FactorRepository`. It must retain factor provenance/units/frequency, must not recalculate factors, and must resolve its own model/inference decisions before use. Phase 3 is authorized as the next phase but is not implemented here.

## Final verdict

PHASE 2 COMPLETE WITH NON-BLOCKING WARNINGS
